Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients

Human Psychopharmacology

Volumn 26, Issue 2, 2011, Pages 168-171

  Rybakowski, Janusz K ^a   Skibinska, Maria ^a   Suwalska, Aleksandra ^a   Leszczynska Rodziewicz, Anna ^a   Kaczmarek, Leszek ^b   Hauser, Joanna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

bipolar disorder; lithium response; matrix metalloproteinase 9; polymorphism

Indexed keywords

GELATINASE B; LITHIUM;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; DNA POLYMORPHISM; DRUG RESPONSE; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; BIPOLAR DISORDER; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES;

EID: 79956282922     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1182     Document Type: Article

References (25)

1. BALANCE investigators and collaborators, Geddes JR, Goodwin GM, Rendell J, et al,. 2010. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomized open-label trial. Lancet 375: 385-395.
2. Czerski PM, Rybakowski F, Kapelski P, et al,. 2008. Association of tumor necrosis factor -308G/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population. Neuropsychobiology 57: 88-94. (Pubitemid 351859339)
3. Dmitrzak-Weglarz M, Rybakowski JK, Slopien A, et al,. 2006. Dopamine receptor D1 gene -48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population. Neuropsychobiology 53: 51-56.
4. First MB, Spitzer RL, Gibbon M, Williams J., 1996. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). American Psychiatric Press: Washington, DC.
5. Miller SA, Dykaes DD, Polesky HF., 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16: 1215.
6. Mizon-Gerard F, de Groote P, Lamblin N, et al,. 2004. Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction. Eur Heart J 25: 688-693. (Pubitemid 38579498)
7. Nivoli AMA, Murru A, Vieta E., 2010. Lithium: still a cornerstone in the long-term treatment in bipolar disorder ? Neuropsychobiology 62: 27-35.
8. O'Brien WT, Klein PS., 2009. Validationg GSK3 as an in vivo target of lithium action. Biochem Soc Trans 37: 1133-1138.
9. Passmore MJ, Garnham J, Duffy A, et al,. 2003. Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disord 5: 110-114. (Pubitemid 36665393)
10. Rybakowski JK, Dmitrzak-Weglarz M, Suwalska A, Leszczynska-Rodziewicz A, Hauser J., 2009. Dopamine D1 receptor gene polymorphism is associated with prophylactic lithium response in bipolar disorder. Pharmacopsychiatry 42: 20-22.
11. Rybakowski JK, Skibinska M, Kapelski P, Kaczmarek L, Hauser J., 2009. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene in schizophrenia. Schizophr Res 109: 90-93.
12. Rybakowski JK, Skibinska M, Leszczynska-Rodziewicz A, Kaczmarek L, Hauser J., 2009. Matrix metalloproteinase-9 (MMP-9) gene and bipolar mood disorder. Neuromolecular Med 11: 128-132.
13. St Jean PL, Zhang XC, Hart BK, et al,. 1995. Characterization of a dinucleotide repeat in the 92kDa type IV collagenase gene (CLG4B), localization of CLG4B to chromosome 20 and the role of CLG4B in aortic aneurysmal disease. Ann Hum Genet 59: 17-24.
14. Strenlicht MD, Werb Z., 2001. How matrix metalloproteinases regulate cell behavior. Ann Rev Cell Dev Biol 17: 463-516. (Pubitemid 33096184)
15. Szczepankiewicz A, Skibinska M, Hauser J, et al,. 2006. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder. Neuropsychobiology 53: 51-56. (Pubitemid 43254178)
16. Szczepankiewicz A, Rybakowski JK, Suwalska A, et al,. 2006. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients. World J Biol Psychiatry 7: 158-161. (Pubitemid 44132541)
17. Szczepankiewicz A, Rybakowski JK, Skibinska M, et al,. 2009. FYN kinase gene: another glutamatergic gene associated with bipolar disorder ? Neuropsychobiology 59: 178-183.
18. Szczepankiewicz A, Skibinska M, Suwalska A, Hauser J, Rybakowski JK., 2009. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients. Hum Psychopharmacol 24: 287-291.
19. Szklarczyk A, Lapinska J, Rylski M, McKay RDG, Kaczmarek L., 2002. Matrix metalloproteinase -9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 22: 920-930. (Pubitemid 34141772)
20. Takada Y, Fang X, Jamaluddin MS, Boyd DD, Aggarwal BB., 2004. Genetic depletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J Biol Chem 279: 39541-39554. (Pubitemid 39258221)
21. Tu HF, Wu CH, Kao SY, Liu CJ, Liu TY, Lui MT., 2007. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. J Oral Pathol Med 36: 409-414.
22. Turecki G, Grof P, Grof E, et al,. 2001. Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry 6: 570-578. (Pubitemid 32772566)
23. Wilczynski GM, Konopacki FA, Wilczek E, et al,. 2008. Important role of matrix metalloproteinase 9 in epileptogenesis. J Cell Biol 180: 1021-1035. (Pubitemid 351398426)
24. Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S., 1999. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 105: 418-423.
25. Zhang B, Ye S, Herrmann SM, et al,. 1999. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99: 1788-1794. (Pubitemid 29181405)